www.eurpharmacy.com

Farmacia Online de máxima seriedad, confianza y seguridad
Envíos discretos hasta su casa u oficina

Revise suprima
Site search
Obvious advantage Tell a friend and get discount! Want to give it a try?
Lista de categorías

Genérico Telmisartan - Micardis, Micardis Hct

Búsqueda por letra:ABCDEFGHIJKLMNOPQRSTUVWXYZ
Micardis

Genérico Micardis

Telmisartan 20/40mg

El Micardis Genérico se utiliza para tratar la presión arterial alta (hipertensión).
Más informaión »

€0.75 Comprar!
Micardis Hct

Genérico Micardis Hct

Telmisartan - Hydrochlorothiazide 40mg + 12.5mg

El Micardis HTC Genérico se utiliza para tratar la presión arterial alta (hipertensión).
Más informaión »

€1.19 Comprar!
Choose Your language:
Bookmarks sociales
Testimonios de nuestros clientes

Recibí el encargo a tiempo y funciona perfectamente. Mi mujer le da las gracias también, nuestra cama etc... - Mark

Nuestra página de facturación está certificada por:

Secure shopping certificates


Special Offer!

  • Switching to TWYNSTA® allows patients with uncontrolled hypertension on ... - EON: Enhanced Online News (press release)

    Switching to TWYNSTA® allows patients with uncontrolled hypertension on .

  • One Agent Better for RAS Blockade - MedPage Today

    One Agent Better for RAS BlockadeMedPage TodayThe findings are consistent with those from the ONTARGET trial of patients with vascular disease or high-risk diabetes, which showed that both telmisartan (an ARB) and ramipril (an ACE inhibitor) as monotherapy reduced cardiovascular events.

  • Twynsta allows prompt BP control in patients with uncontrolled hypertension - pharmabiz.com

    Twynsta allows prompt BP control in patients with uncontrolled hypertensionpharmabiz.

  • India caught napping on changes in drug dosage - Times of India

    India caught napping on changes in drug dosageTimes of India'It was not earlier known that the drug Modafinil can cause serious skin reactions, that concurrent use of two anti hypertensive agents, Telmisartan with Ramipril is risky,' it added.

  • Boehringer Ingelheim says it is on growth path, as 2011 sales rise 6.2% - The Pharma Letter

    Boehringer Ingelheim says it is on growth path, as 2011 sales rise 6.

Agregar a favoritos
Apuntarse a lista de correo
Trusted. Rx approved.